Wir sind mit live!
Mehr erfahren
Tao Synergies Inc
Profil: TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Mitarbeiter: 4
Nachrichten
Positiv
Neutral
Negativ
Stimmung
3 Monate
Positiv
0 %
Neutral
0 %
Negativ
0 %
Kursdiagramme mit Lightweight Charts™ umgesetzt